Glaukos (GKOS) Competitors

Koninklijke Philips (NYSE:PHG) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, community ranking, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

Does the MarketBeat Community prefer PHG or GKOS?

Glaukos received 73 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 65.03% of users gave Glaukos an outperform vote while only 56.69% of users gave Koninklijke Philips an outperform vote.

Company	Underperform	Outperform
Koninklijke Philips	Outperform Votes 377 56.69%	Underperform Votes 288 43.31%
Glaukos	Outperform Votes 450 65.03%	Underperform Votes 242 34.97%

Does the media refer more to PHG or GKOS?

In the previous week, Koninklijke Philips had 20 more articles in the media than Glaukos. MarketBeat recorded 43 mentions for Koninklijke Philips and 23 mentions for Glaukos. Glaukos' average media sentiment score of 0.29 beat Koninklijke Philips' score of 0.24 indicating that Glaukos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	8 Very Positive mention(s)	8 Positive mention(s)	18 Neutral mention(s)	7 Negative mention(s)	0 Very Negative mention(s)	Neutral
Glaukos	5 Very Positive mention(s)	1 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders and institutionals believe in PHG or GKOS?

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 99.0% of Glaukos shares are owned by institutional investors. 6.4% of Glaukos shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has preferable valuation and earnings, PHG or GKOS?

Glaukos has lower revenue, but higher earnings than Koninklijke Philips. Glaukos is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$19.50B	1.23	-$503.27M	-$0.84	-30.40
Glaukos	$314.71M	22.08	-$134.66M	-$3.02	-41.73

Do analysts recommend PHG or GKOS?

Glaukos has a consensus target price of $163.25, indicating a potential upside of 29.53%. Given Glaukos' stronger consensus rating and higher probable upside, analysts clearly believe Glaukos is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Glaukos	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92

Is PHG or GKOS more profitable?

Koninklijke Philips has a net margin of -3.88% compared to Glaukos' net margin of -42.43%. Koninklijke Philips' return on equity of 10.94% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	-3.88%	10.94%	4.42%
Glaukos	-42.43%	-18.99%	-11.47%

Which has more risk & volatility, PHG or GKOS?

Koninklijke Philips has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500.

Summary

Glaukos beats Koninklijke Philips on 12 of the 19 factors compared between the two stocks.